1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurological Diagnostic and Monitoring Equipment Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurological Diagnostic and Monitoring Equipment Market, Asia-Pacific
3.1 Neurological Diagnostic and Monitoring Equipment Market, Asia-Pacific, Revenue ($m), 2018-2033
3.2 Neurological Diagnostic and Monitoring Equipment Market, Asia-Pacific, Revenue ($m), 2018-2033
3.3 Neurological Diagnostic and Monitoring Equipment Market, Asia-Pacific, Volume (Units), 2018-2033
3.4 Neurological Diagnostic and Monitoring Equipment Market, Asia-Pacific, Volume (Units), 2018-2033
3.5 Neurological Diagnostic and Monitoring Equipment Market, Asia-Pacific, Company Share by Revenue ($m), 2025
4 Neurological Diagnostic and Monitoring Equipment Market, Australia
4.1 Neurological Diagnostic and Monitoring Equipment Market, Australia, Revenue ($m), 2018-2033
4.1.1 Electrical Activity Testing Market, Australia, Revenue ($m), by Segment, 2018-2033
4.1.2 ICP Monitoring Devices Market, Australia, Revenue ($m), by Segment, 2018-2033
4.2 Neurological Diagnostic and Monitoring Equipment Market, Australia, Volume (Units), 2018-2033
4.2.1 Electrical Activity Testing Market, Australia, Volume (Units), by Segment, 2018-2033
4.2.2 ICP Monitoring Devices Market, Australia, Volume (Units), by Segment, 2018-2033
4.3 Neurological Diagnostic and Monitoring Equipment Market, Australia, Average Price ($), 2018-2033
4.4 Neurological Diagnostic and Monitoring Equipment Market, Australia, Company Share by Revenue ($m), 2025
5 Neurological Diagnostic and Monitoring Equipment Market, China
5.1 Neurological Diagnostic and Monitoring Equipment Market, China, Revenue ($m), 2018-2033
5.1.1 Electrical Activity Testing Market, China, Revenue ($m), by Segment, 2018-2033
5.1.2 ICP Monitoring Devices Market, China, Revenue ($m), by Segment, 2018-2033
5.2 Neurological Diagnostic and Monitoring Equipment Market, China, Volume (Units), 2018-2033
5.2.1 Electrical Activity Testing Market, China, Volume (Units), by Segment, 2018-2033
5.2.2 ICP Monitoring Devices Market, China, Volume (Units), by Segment, 2018-2033
5.3 Neurological Diagnostic and Monitoring Equipment Market, China, Average Price ($), 2018-2033
5.4 Neurological Diagnostic and Monitoring Equipment Market, China, Company Share by Revenue ($m), 2025
6 Neurological Diagnostic and Monitoring Equipment Market, India
6.1 Neurological Diagnostic and Monitoring Equipment Market, India, Revenue ($m), 2018-2033
6.1.1 Electrical Activity Testing Market, India, Revenue ($m), by Segment, 2018-2033
6.1.2 ICP Monitoring Devices Market, India, Revenue ($m), by Segment, 2018-2033
6.2 Neurological Diagnostic and Monitoring Equipment Market, India, Volume (Units), 2018-2033
6.2.1 Electrical Activity Testing Market, India, Volume (Units), by Segment, 2018-2033
6.2.2 ICP Monitoring Devices Market, India, Volume (Units), by Segment, 2018-2033
6.3 Neurological Diagnostic and Monitoring Equipment Market, India, Average Price ($), 2018-2033
6.4 Neurological Diagnostic and Monitoring Equipment Market, India, Company Share by Revenue ($m), 2025
7 Neurological Diagnostic and Monitoring Equipment Market, Japan
7.1 Neurological Diagnostic and Monitoring Equipment Market, Japan, Revenue ($m), 2018-2033
7.1.1 Electrical Activity Testing Market, Japan, Revenue ($m), by Segment, 2018-2033
7.1.2 ICP Monitoring Devices Market, Japan, Revenue ($m), by Segment, 2018-2033
7.2 Neurological Diagnostic and Monitoring Equipment Market, Japan, Volume (Units), 2018-2033
7.2.1 Electrical Activity Testing Market, Japan, Volume (Units), by Segment, 2018-2033
7.2.2 ICP Monitoring Devices Market, Japan, Volume (Units), by Segment, 2018-2033
7.3 Neurological Diagnostic and Monitoring Equipment Market, Japan, Average Price ($), 2018-2033
7.4 Neurological Diagnostic and Monitoring Equipment Market, Japan, Company Share by Revenue ($m), 2025
8 Neurological Diagnostic and Monitoring Equipment Market, South Korea
8.1 Neurological Diagnostic and Monitoring Equipment Market, South Korea, Revenue ($m), 2018-2033
8.1.1 Electrical Activity Testing Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.1.2 ICP Monitoring Devices Market, South Korea, Revenue ($m), by Segment, 2018-2033
8.2 Neurological Diagnostic and Monitoring Equipment Market, South Korea, Volume (Units), 2018-2033
8.2.1 Electrical Activity Testing Market, South Korea, Volume (Units), by Segment, 2018-2033
8.2.2 ICP Monitoring Devices Market, South Korea, Volume (Units), by Segment, 2018-2033
8.3 Neurological Diagnostic and Monitoring Equipment Market, South Korea, Average Price ($), 2018-2033
8.4 Neurological Diagnostic and Monitoring Equipment Market, South Korea, Company Share by Revenue ($m), 2025
9 Overview of Key Companies in Asia-Pacific Neurological Diagnostic and Monitoring Equipment Market
9.1 Nihon Kohden Corp
9.1.1 Company Overview
9.2 Natus Medical Inc
9.2.1 Company Overview
9.3 Medtronic Plc
9.3.1 Company Overview
9.4 Masimo Corp
9.4.1 Company Overview
9.5 Integra LifeSciences Corp
9.5.1 Company Overview
9.6 Compumedics Ltd
9.6.1 Company Overview
10 Neurological Diagnostic and Monitoring Equipment Market Pipeline Products
11 Recent Developments
11.1 Corporate Communications
11.1.1 Dec 01, 2025: Control Bionics Appoints Stephen Rix to the Board of Directors
11.1.2 Nov 19, 2025: Control Bionics Announces Resignation of CBL Chairman – Dr Samuel Straface
11.1.3 Nov 11, 2025: Novel Technique Enhances Brain-State Detection
11.1.4 Oct 09, 2025: M6A RNA Methylation Sequencing Service Reveals New Targets for Alzheimer's Disease
11.2 Financial Announcements
11.2.1 Feb 05, 2026: Nihon Kohden Announces Consolidated Financial Results for the Third Quarter of FY2025 ending March 31, 2026
11.2.2 Jun 30, 2025: CTQ FY25 Preliminary Full Year Results
11.3 Government and Public Interest
11.3.1 Nov 07, 2025: Empowering National Medical Device Innovation and Promoting Industry Integration
11.4 Other Significant Developments
11.4.1 Nov 24, 2025: NeuroPace Announces Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services
11.4.2 Nov 07, 2025: Empowering National Medical Device Innovation and Promoting Industry Integration
11.4.3 Oct 09, 2025: M6A RNA Methylation Sequencing Service Reveals New Targets for Alzheimer's Disease
11.4.4 Sep 29, 2025: PolyU And Zhejiang Qiangnao Technology Sign MOU To Explore Joint Research Centre For Brain-Computer Interface
11.5 Product News
11.5.1 Nov 15, 2025: Evidence Builds for Disrupted Mitochondria as Cause of Parkinson’s
11.5.2 Nov 03, 2025: Wearable Brain Imaging Technology Sheds New Light on Multiple Sclerosis
11.5.3 Oct 21, 2025: Nexalin’s DIFS Neurostimulation Demonstrates Cognitive Improvements in Alzheimer’s and Dementia
11.5.4 Oct 16, 2025: Discovery of New Phase Separation Regulatory Factor Linked to Neurodegenerative Diseases
11.5.5 Oct 09, 2025: M6A RNA Methylation Sequencing Service Reveals New Targets for Alzheimer's Disease
11.5.6 Sep 10, 2025: Robotimize Showcases Hospital-to-Community Neurorehabilitation at AOCNR 2025 in Yogyakarta
11.5.7 Jul 14, 2025: University of Queensland develops device for drug delivery to brain
11.6 Strategy And Business Planning
11.6.1 Sep 29, 2025: PolyU And Zhejiang Qiangnao Technology Sign MOU To Explore Joint Research Centre For Brain-Computer Interface
12 Appendix
12.1 Research Methodology
12.1.1 Coverage
12.1.2 Secondary Research
12.1.3 Primary Research
12.1.4 Market Modeling and Forecasting
12.1.5 Company Share Analysis
12.1.6 Benchmarking
12.2 GlobalData Consulting
12.3 Contact Us
12.4 Disclaimer